Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs

Journal of Applied Physiology

Volumn 83, Issue 5, 1997, Pages 1508-1516

  Miyahara, Takashige ^a   Shibamoto, Toshishige ^a   Wang, Hong Gang ^a   Koyama, Shozo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ascaris suum antigen; Filtration coefficient; Histamine; Indomethacin; Platelet activating factor

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; ASCARIS ANTIGEN; DIPHENHYDRAMINE; INDOMETACIN; SERATRODAST; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE;

ANAPHYLAXIS; ANIMAL TISSUE; ARTICLE; ASCARIS SUUM; BLOOD COMPONENT; BLOOD VESSEL PERMEABILITY; DOG; FILTRATION; ISOLATED LUNG; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030707732     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.83.5.1508     Document Type: Article

References (37)

1. Allison, R. C., K. T. Marble, E. M. Hernandez, M. I. Townsley, and A. E. Taylor. Attenuation of permeability lung injury after phorbol myristate acetate by verapamil and OKY-046. Am. Rev. Respir. Dis. 134: 93-100, 1986.
2. Barnard, J. W., P. S. Wilson, T. M. Moore, W. J. Thompson, and A. E. Taylor. Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J. Appl. Physiol. 74: 2940-2948, 1993.
3. Carlson, R. W., R. C. Schaeffer, V. K. Puri, A. P. Brennan, and M. H. Weil. Hypovolemia and permeability pulmonary edema associated with anaphylaxis. Crit. Care Med. 9: 883-885, 1981.
4. Creese, B. R., and D. M. Temple. The effect of indomethacin on anaphylactic contraction and histamine release in guinea pig lung parenchymal strips. Arch. Int. Pharmacol. 281: 265-276, 1986.
5. Drake, R., K. A. Gaar, and A. E. Taylor. Estimation of the filtration coefficient of pulmonary exchange vessels. Am. J. Physiol. 234 (Heart Circ. Physiol. 3): H266-H274, 1978.
6. Enzan, K., S. Kei, H. Inaba, and N. Yoshioka. Inhibition of pulmonary hypertensive response after antigen challenge. Shock 4: 294-297, 1995.
7. Henderson, W. R., Jr. Eicosanoids and platelet-activating factor in allergic respiratory diseases. Am. Rev. Respir. Dis. 143: S86-S90, 1991.
8. Higgs, G. A., S. Moncada, J. A. Salmon, and K. Seager. The source of thromboxane and prostaglandins in experimental inflammation. Br. J. Pharmacol. 79: 863-868, 1983.
9. 2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J. Immunol. 133: 2138-2144, 1984.
10. Kleeberger, S. R., J. Kolbe, N. F. Adkinson, Jr., S. P. Peters, and E. W. Spannhake. Central role of cyclooxygenase in the response of canine peripheral airways to antigen. J. Appl. Physiol. 61: 1309-1315, 1986.
11. Kleeberger, S. R., J. Kolbe, N. F. Adkinson, Jr., S. P. Peters, and E. W. Spannhake. Thromboxane contributes to the immediate antigenic response of canine airways. J. Appl. Physiol. 62: 1589-1595, 1987.
12. Koyama, S., T. Fujita, H. Uematsu, T. Shibamoto, M. Aibiki, and S. Kojima. Inhibitory effect of renal nerve activity during canine anaphylactic hypotension. Am. J. Physiol. 258 (Regulatory Integrative Comp. Physiol. 27): R383-R387, 1990.
13. Krell, R. D. Investigation of the role of histamine in antigen-induced bronchoconstriction in the ascaris-hypersensitive dog. Br. J. Pharmacol. 62: 519-528, 1978.
14. 2 receptor by an anti-asthmatic agent AA-2414. Biol. Pharm. Bull. 17: 383-385, 1994.
15. Lohman, I. C., and M. Halonen. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit. Am. Rev. Respir. Dis. 142: 390-397, 1990.
16. Mazza, G., A. H. Whiting, M. J. Day, and W. P. Duffus. Preparation of monoclonal antibodies specific for the subclasses of canine IgG. Res. Vet. Sci. 57: 140-145, 1994.
17. McBride, W. T., M. A. Armstrong, and S. J. McBride. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia 51: 465-473, 1996.
18. Mckeon, S. E., and J. P. Opdebeeck. IgG and IgE antibodies against antigens of the cat flea, Ctenocephalides felis felis, in sera of allergic and non-allergic dogs. Int. J. Parasitol. 24: 259-263, 1994.
19. Metzger, W. J., G. W. Hunninghake, and H. B. Richerson. Late asthmatic responses: inquiry into mechanisms and significance. Clin. Rev. Allergy 3: 145-165, 1985.
20. Mitsuhata, H., J. Saitoh, H. Takeuchi, N. Hasome, Y. Horiguchi, and R. Shimizu. Production of nitric oxide in anaphylaxis in rabbits. Shock 2: 381-384, 1994.
21. 2, and prostaglandins during systemic anaphylaxis in sheep. Am J. Physiol. 261 (Heart Circ. Physiol. 30): H782-H792, 1991.
22. Patterson, R., M. Roberts, and J. J. Pruzansky. Comparisons of reaginic antibodies from three species. J. Immunol. 102: 466-475, 1969.
23. Pinckard, R. N., R. S. Farr, and D. J. Hanahan. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J. Immunol. 123: 1847-1857, 1979.
24. Rippe, B., J. C. Parker, M. I. Townsley, N. A. Mortillaro, and A. E. Taylor. Segmental vascular resistance and compliance in dog lung J. Appl. Physiol. 62: 1206-1215, 1987.
25. Schleimer, R. P., E. S. Schulman, D. W. MacGlashan, Jr., S. P. Peters, E. C. Hayes, G. K. Adams III, L. M. Lichtenstein, and N. F. Adkinson, Jr. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J. Clin. Invest. 71: 1830-1835, 1983.
26. Selig, W. N., J. E. Tocker, S. A. Tannu, F. Cerasoli, and S. K. Durham. Pharmacologic modulation of antigen-induced pulmonary responses in the perfused guinea pig lung. Am. Rev. Respir. Dis. 147: 262-269, 1993.
27. 4 increases extravascular lung water in the dog. Circ. Shock 21: 121-128, 1987.
28. Shibamoto, T., T. Hayashi, F. Sawano, Y. Saeki, Y. Matsuda, M. Kawamoto, and S. Koyama. Pulmonary vascular response to anaphylaxis in isolated canine lungs. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R1024-R1029, 1992.
29. Shibamoto, T., J. C. Parker, A. E. Taylor, and M. I. Townsley. Derecruitment of filtration surface area in paraquat-injured isolated dog lungs. J. Appl. Physiol. 68: 1581-1589, 1990.
30. 2 analogue on vascular resistance distribution and permeability in isolated blood-perfused dog lungs. Lung 173: 209-221, 1995.
31. Shibamoto, T., Y. Yamaguchi, T. Hayashi, Y. Saeki, M. Kawamoto, and S. Koyama. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1454-H1459, 1993.
32. Silverman, H. J., W. R. Taylor, P. L. Smith, A. K. Sobotka, S. Permutt, L. M. Lichtenstein, and E. R. Bleecker. Effects of antihistamines on the cardiopulmonary changes due to canine anaphylaxis. J. Appl. Physiol. 64: 210-217, 1988.
33. Smith, L. J. The role of platelet-activating factor in asthma. Am. Rev. Respir. Dis. 143: S100-S102, 1991.
34. Smith, P. L., A. K. Sobotka, E. R. Bleecker, R. Traystan, A. P. Kaplan, H. Gralnick, M. D. Valentine, S. Permutt, and L. M. Lichtenstein. Physiologic manifestations of human anaphylaxis. J. Clin. Invest. 66: 1072-1080, 1980.
35. Stanworth, D. R. Inter-receptor relationships in effector cell triggering, with particular reference to the mast cell. Mol. Immunol. 25: 1213-1215, 1988.
36. Terashita, T., M. Kawamura, M. Takatani, S. Tsushima, Y. Imura, and K. Nishikawa. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J. Pharmacol. Exp. Ther. 260: 748-755, 1992.
37. Townsley, M. I., R. J. Korthuis, B. Rippe, J. C. Parker, and A. E. Taylor. Validation of double vascular occlusion method for Pc,i in the lung and skeletal muscle. J. Appl. Physiol. 61: 127-132, 1986.